Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

NanoViricides' anti-HIV candidates efficacious against two HIV-1 isolates in vitro

June 10, 2010

Opal Therapeutics and MGH to jointly develop HIV vaccine

June 9, 2010

Artec reports improvements of Tubercin for HIV/AIDS

June 2, 2010

ARCA launches phase I trial of GeoVax Labs' HIV vaccine

June 1, 2010

NanoViricides and UCSF collaborate to test anti-HIV drug candidates

May 20, 2010

Chimerix initiates first-in-human phase I study of CMX-157

May 17, 2010

New FDA dosing guidelines for colchicine given with protease inhibitors

May 10, 2010

Chinese scientists claim novel anti-HIV akaloids

May 10, 2010

FDA approves once-daily dosing of Kaletra for previously treated HIV patients

April 30, 2010

Tibotek discloses novel CYP450 inhibitors as boosters for anti-HIV agents

April 30, 2010

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...